Nutrisystem, Inc., Fort Washington, Pa., greeted 2015 with a new weight loss program: Fast 5+, a new program to help customers lose five pounds PLUS one inch off their waist in their first week of dieting—or their money back guaranteed.

Building on success with its Up&Go liquid meal drinks, Australian Health & Nutrition Association Limited, Berkeley Vale, NSW, has extended its Sanitarium line with two new reduced-sugar varieties: Choc Ice and Vanilla Ice.

General Mills, Minneapolis, says it has improved the health profile of 76% of its US retail sales volume since 2005, when it first established a “Health Metric” to encourage progress on nutrition and health improvements.

Extend Nutrition, St. Louis, says its new sugar-free and gluten-free protein bars are clinically proven to help control blood sugar for six to nine hours. Officials say new Cookies & Cream and Chocolate & Caramel bars are currently available at extendbar.com, with retail sales to begin later this year.

Extend Nutrition, St. Louis, introduces an easy-to-follow “Snack-2-Health Kit.” Officials note that no lifestyle changes required there’s no program to follow. Consumers just have to eat two snacks per day.

Zinc, an important mineral in human health, appears to affect how the immune system responds to stimulation, especially inflammation, new research from Oregon State University shows.

Today's consumers want and expect more than great taste and belly-filling from the foods and beverages they consume.

BENEO used Europe’s recent ISM 2015 as an opportunity to showcase its expanded “Sweets Collection,” including its latest range of new product concepts and corresponding samples for sugar-free and low glycemic hard candies. The new concepts offered visitors inspirational ideas on how to develop products that meet consumer demand for sweetness and indulgence, but benefit from a healthier nutritional profile.

Compound Solutions Inc.’s TeaCrine is the world’s first and only nature-identical theacrine compound, designed to increase energy and enhance focus and concentration without fatigued crash or tolerance buildup.

Lonza announced the publication of the results of two early pilot studies performed using soy lecithin-derived phosphatidylserine (PS) and phosphatidic acid (PA), which appeared in the November issue of Advances in Therapy.